Geron | GERN - Le Coût Des Ventes





Le Coût Des Ventes Changement Date
Amgen USD 1.6B 187M 2026-03
Bio Techne USD 103.13M 1.47M 2026-03
Cassava Sciences USD 3.96M 1.16M 2025-09
Cytokinetics USD 160K 104.24M 2026-03
Esperion Therapeutics USD 27.85M 13.43M 2025-12
Exelixis USD 19.95M 6.53M 2026-03
Genmab DKK 81M 23M 2025-12
Geron USD 1.69M 386K 2026-03
Gilead Sciences USD 1.44B 174M 2026-03
Incyte USD 104.5M 16.68M 2026-03
MacroGenics USD 9.53M 585K 2026-03
Novartis USD 3.46B 83M 2026-03
Novavax USD 22.1M 608K 2025-12